Lexeo Therapeutics
USEntry
2021
Hold
2yr
Exit
2023
Who owns Lexeo Therapeutics?
Lexeo Therapeutics was owned by Lundbeckfonden BioCapital through Lundbeckfonden BioCapital (2009 vintage) from 2021 to 2023, exited via IPO.
Hand-verified · updated 2026-08-18
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2023
More from Lundbeckfonden BioCapital
Other portfolio companies in the same fund.
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
FranceTrack Lexeo Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Lexeo Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Lexeo Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue